These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 6888239)

  • 61. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
    LeWitt P; Oakes D; Cui L
    Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Treatment of disturbances of extrapyramidal system with methixene hydrochloride].
    Kuromaru S; Funasaka K; Shuta K
    No To Shinkei; 1969 Nov; 21(11):1301-9. PubMed ID: 5394922
    [No Abstract]   [Full Text] [Related]  

  • 63. Role of midazolam in parkinsonian tremors: to use or not to use.
    Chowdhury T; Cappellani RB; Kowalski SE
    Can J Neurol Sci; 2013 Jul; 40(4):616. PubMed ID: 23946975
    [No Abstract]   [Full Text] [Related]  

  • 64. Clinical spectrum of Parkinson's disease from Pakistan.
    Khealani BA; Baig SM
    Singapore Med J; 2006 Dec; 47(12):1075-9. PubMed ID: 17139405
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficacy and safety of piribedil in early combination with L-dopa in the treatment of Parkinson's disease: a 6-month open study.
    Suwantamee J; Nidhinandana S; Srisuwananukorn S; Laptikultham S; Pisarnpong A; Chankrachang S; Bundhukul A
    J Med Assoc Thai; 2004 Nov; 87(11):1293-300. PubMed ID: 15825702
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The efficacy of the Umex treatment of parkinsonism patients in the initial stage of the disease].
    Fedorova NV; Glozman ZhM; Saltykova NM
    Ter Arkh; 1995; 67(10):75-7. PubMed ID: 8779116
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease.
    Sturman MM; Vaillancourt DE; Metman LV; Bakay RA; Corcos DM
    Brain; 2004 Sep; 127(Pt 9):2131-43. PubMed ID: 15240437
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Lisuride in extrapyramidal disorders: a possible mechanism of action.
    Bosio A; Bassi S; Govoni S; Spano PF; Trabucchi M; Covelli V; Frattola L
    Adv Neurol; 1984; 40():523-6. PubMed ID: 6695630
    [No Abstract]   [Full Text] [Related]  

  • 69. [Indications for beta-blockers in neurology].
    Schoenen J; Delwaide PJ
    Acta Clin Belg; 1978; 33(2):130-40. PubMed ID: 358715
    [No Abstract]   [Full Text] [Related]  

  • 70. [Current medical treatment in the disorders of the extrapyramidal nervous system].
    Rizzo PA; Morocutti A
    Clin Ter; 1975 Aug; 74(4):313-24. PubMed ID: 1227750
    [No Abstract]   [Full Text] [Related]  

  • 71. The abrupt withdrawal of antiparkinsonian drugs in schizophrenic patients.
    McClelland HA; Blessed G; Bhate S; Ali N; Clarke PA
    Br J Psychiatry; 1974 Feb; 124(579):151-9. PubMed ID: 4596671
    [No Abstract]   [Full Text] [Related]  

  • 72. [Action of amantadine on parkinsonian tremor].
    Agnoli A; Casacchia M; Ruggieri S; Volante F; Accornero N
    Minerva Med; 1971 Oct; 62(82):3990-3. PubMed ID: 5125061
    [No Abstract]   [Full Text] [Related]  

  • 73. Efficacy of zonisamide in a case of Parkinson's disease with intractable resting and re-emergent tremor.
    Iijima M; Osawa M; Kobayashi M; Uchiyama S
    Eur J Neurol; 2011 Apr; 18(4):e43-4. PubMed ID: 21159065
    [No Abstract]   [Full Text] [Related]  

  • 74. [Semeiotics of tremors].
    Pasquazzi M
    Policlinico Prat; 1967 Feb; 74(6):199-204. PubMed ID: 5601117
    [No Abstract]   [Full Text] [Related]  

  • 75. [The energy and fractal characteristics of the physiological and pathological tremors of man's hand].
    Dik OE; Romanov SP; Nozdrachev AD
    Fiziol Cheloveka; 2010; 36(2):92-100. PubMed ID: 20432697
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
    Tkachev RA; Markova ED; Gotovtseva EV; Barkhatova VP; Ivanova-Smolenskaia IA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):513-9. PubMed ID: 4705405
    [No Abstract]   [Full Text] [Related]  

  • 77. [Kr 339, a new tremor-inhibiting preparation for the therapy of Parkinson's syndrome].
    Avenarius HJ; Gerstenbrand F
    Wien Klin Wochenschr; 1968 Jun; 80(23):460-2. PubMed ID: 5704572
    [No Abstract]   [Full Text] [Related]  

  • 78. Re-emergent tremor in a patient with Parkinson's disease.
    Noda K; Hattori N; Okuma Y
    BMJ Case Rep; 2016 Aug; 2016():. PubMed ID: 27495177
    [No Abstract]   [Full Text] [Related]  

  • 79. [Phenibut potentiation of the therapeutic action of antiparkinson agents].
    Gol'dblat IuV; Lapin IP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(8):1146-8. PubMed ID: 3776387
    [TBL] [Abstract][Full Text] [Related]  

  • 80. ["Drug-free vacations" in parkinsonism patients].
    Levin IaI
    Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(5):26-8. PubMed ID: 7900445
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.